Cargando…

Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now?

Exosomes (Exos) are nano-sized extracellular vesicles constitutively released by both prokaryotic and eukaryotic cells. Their role as inter-cellular messengers involved in both physiological and pathological processes has overwhelmingly come to light in the last decade, and their contribution to can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannavola, Francesco, Salerno, Tina, Passarelli, Anna, Tucci, Marco, Internò, Valeria, Silvestris, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593071/ https://www.ncbi.nlm.nih.gov/pubmed/31275854 http://dx.doi.org/10.3389/fonc.2019.00521

Ejemplares similares

Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer
por: Internò, Valeria, et al.
Publicado: (2020)

Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
por: Tucci, Marco, et al.
Publicado: (2019)

Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity
por: Tucci, Marco, et al.
Publicado: (2018)

Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis
por: Mannavola, Francesco, et al.
Publicado: (2019)

Immune system and melanoma biology: a balance between immunosurveillance and immune escape
por: Passarelli, Anna, et al.
Publicado: (2017)

Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021)

Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: a potential role as additional prognostic marker
por: Stucci, Stefania, et al.
Publicado: (2015)

The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice
por: Stucci, Luigia Stefania, et al.
Publicado: (2021)

Colorectal Cancer Biomarkers: Where Are We Now?
por: Gonzalez-Pons, Maria, et al.
Publicado: (2015)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Genetic counseling globally: Where are we now?
por: Ormond, Kelly E., et al.
Publicado: (2018)

The genetic patterns of bladder cancer. Where do we stand now?
por: Salagierski, Maciej
Publicado: (2013)

COVID-19 and liver disease: where are we now?
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

A Lipidomic Approach to Identify Potential Biomarkers in Exosomes From Melanoma Cells With Different Metastatic Potential
por: Lobasso, Simona, et al.
Publicado: (2021)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications
por: Internò, Valeria, et al.
Publicado: (2022)

Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
por: Tovoli, Francesco, et al.
Publicado: (2020)

Cancer treatment data available in European cancer registries: Where are we and where are we going?
por: Giusti, Francesco, et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Accelerated Partial Breast Irradiation (APBI): Where Are We Now?
por: Goldberg, Mira, et al.
Publicado: (2020)

Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?
por: Mjahed, Ribal Bou, et al.
Publicado: (2022)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Personal genomics: Where are we now?
por: Angrist, Misha
Publicado: (2016)

9. GFR - Where are We Now?
por: Delanghe, Joris R.
Publicado: (2009)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Intracranial Atherosclerosis: Where Are We Now?
por: Kim, Jong S.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kbqfsv8bokfanh8ie5eruf8bub